Implications of SARS-CoV-2-Associated Myocarditis in the Medical Evaluation of Athletes
- 17 November 2020
- journal article
- review article
- Published by SAGE Publications in Sports Health: a Multidisciplinary Approach
- Vol. 13 (2), 145-148
- https://doi.org/10.1177/1941738120974747
Abstract
Myocarditis is a known cause of death in athletes. As we consider clearance of athletes to participate in sports during the COVID-19 pandemic, we offer a brief review of the myocardial effects of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) through the lens of what is known about myocarditis and exercise. All athletes should be queried about any recent illness suspicious for COVID-19 prior to sports participation. The PubMed database was evaluated through 2020, with the following keywords: myocarditis, COVID-19, SARS-CoV-2, cardiac, and athletes. Selected articles identified through the primary search, along with position statements from around the world, and the relevant references from those articles, were reviewed for pertinent clinical information regarding the identification, evaluation, risk stratification, and management of myocarditis in patients, including athletes, with and without SARS-CoV-2. Systematic review. Level 3. Since myocarditis can present with a variety of symptoms, and can be asymptomatic, the sports medicine physician needs to have a heightened awareness of athletes who may have had COVID-19 and be at risk for myocarditis and should have a low threshold to obtain further cardiovascular testing. Symptomatic athletes with SARS-CoV-2 may require cardiac evaluation including an electrocardiogram and possibly an echocardiogram. Athletes with cardiomyopathy may benefit from cardiac magnetic resonance imaging in the recovery phase and, rarely, endocardial biopsy. Myocarditis is a known cause of sudden cardiac death in athletes. The currently reported rates of cardiac involvement of COVID-19 makes myocarditis a risk, and physicians who clear athletes for participation in sport as well as sideline personnel should be versed with the diagnosis, management, and clearance of athletes with suspected myocarditis. Given the potentially increased risk of arrhythmias, sideline personnel should practice their emergency action plans and be comfortable using an automated external defibrillator.Keywords
This publication has 55 references indexed in Scilit:
- MyocarditisThe New England Journal of Medicine, 2009
- Clinicopathological features of paediatric deaths due to myocarditis: an autopsy seriesArchives of Disease in Childhood, 2008
- Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditisEuropean Journal of Preventive Cardiology, 2006
- Trends in Sudden Cardiovascular Death in Young Competitive Athletes After Implementation of a Preparticipation Screening ProgramJAMA, 2006
- Arrhythmogenic right ventricular cardiomyopathy/dysplasia: is there a role for viruses?Cardiovascular Pathology, 2006
- Sudden Death in Young AthletesThe New England Journal of Medicine, 2003
- From Myocarditis to Cardiomyopathy: Mechanisms of Inflammation and Cell DeathJournal of the American College of Cardiology, 1999
- The arrhythmogenic right ventricle. Dysplasia versus cardiomyopathyHeart and Vessels, 1995
- Sudden Death in Young Athletes -- Lessons from the Hank Gathers AffairThe New England Journal of Medicine, 1993
- Exercise in coxsackie B3 myocarditis: Effects on heart lymphocyte subpopulations and the inflammatory reactionAmerican Heart Journal, 1989